Hitachi, Ltd. vs Humana Inc.: Strategic Comparison

This in-depth comparison examines Hitachi, Ltd. and Humana Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Hitachi, Ltd. on its own, evaluating Humana Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Hitachi, Ltd. and Humana Inc. is widest.

On the headline numbers, Hitachi, Ltd. reports annual revenue of ~$70.9B against $129.7B for Humana Inc., while their respective market capitalizations stand at $157.8B and $48.2B. Hitachi, Ltd. is headquartered in Japan and Humana Inc. in United States, and those different home markets shape how each company competes.

Hitachi, Ltd.: Hitachi is a Japanese industrial technology group founded in 1910 and headquartered in Chiyoda, Tokyo. It is listed on the Tokyo Stock Exchange (6501), had 287,901 employees at March 31, 2026, and is led by President and CEO Toshiaki Tokunaga, with Keiji Kojima as Executive Chairman. Many people still link the name to TVs, hard drives, or home appliances, but those businesses have been sold or are being sold. Today's Hitachi builds power grid equipment through Hitachi Energy, trains and signalling through Hitachi Rail, IT systems and digital engineering through its Digital Systems & Services sector and GlobalLogic, and industrial and building equipment through Connective Industries.

Humana Inc.: Humana Inc. is a Fortune 50 health company headquartered in Louisville, Kentucky. It serves roughly 7.2 million individual and group Medicare Advantage members, millions of stand-alone Part D, Medicaid, and TRICARE beneficiaries, and patients of its CenterWell clinics, pharmacy, and home health services. Unlike diversified rivals, Humana gets nearly all of its medical membership from government-funded programs, so it is effectively a bet on Medicare Advantage and senior care.

Hitachi, Ltd. and Humana Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Hitachi, Ltd. and Humana Inc..

Hitachi, Ltd. business model: Hitachi is a B2B infrastructure and IT company. It sells long-lived physical assets (transformers, HVDC converter stations, trains, signalling, elevators, semiconductor metrology tools) and then earns recurring service, maintenance, and software revenue on that installed base. Lumada is the umbrella for the data, AI, and digital services layered on top, and Hitachi reports Lumada as a growing share of total revenue. The four reporting sectors are Digital Systems & Services, Energy, Mobility, and Connective Industries. Customers are utilities, rail operators, governments, banks, and manufacturers, and many contracts run for years, which gives Hitachi a large order backlog and revenue visibility.

Humana Inc. business model: Humana runs two reporting segments. The Insurance segment sells individual and group Medicare Advantage plans, stand-alone Medicare Part D drug plans, state Medicaid contracts, and administers TRICARE for the Defense Health Agency. It is paid largely by the federal government on a per-member, per-month basis adjusted for each member's health risk, and keeps the difference between those premiums and medical and pharmacy claims plus operating costs. The CenterWell segment provides services: CenterWell Senior Primary Care clinics, CenterWell Pharmacy (mail-order and specialty), and CenterWell Home Health. CenterWell serves Humana members and members of other plans, and it gives Humana direct influence over care costs for its own seniors.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Hitachi, Ltd. stack up against those of Humana Inc..

Hitachi, Ltd. competitive advantage: Hitachi's edge is owning both the operational technology and the IT. Hitachi Energy (built on ABB's former Power Grids business) is one of a handful of suppliers able to deliver HVDC links and large power transformers at scale, Hitachi Rail became a top-tier signalling supplier after buying Thales GTS in 2024, and GlobalLogic plus Hitachi's Japanese IT business supply the software. Few rivals combine all three, and the installed base of grids, trains, and IT systems feeds long-term service revenue.

Humana Inc. competitive advantage: Humana's edge is depth in one market. It is the second-largest Medicare Advantage insurer after UnitedHealth, it has decades of experience pricing senior risk, and it owns care-delivery assets built for seniors: CenterWell Senior Primary Care clinics, a large mail-order pharmacy, and CenterWell Home Health. Owning those services lets Humana manage chronic conditions and pharmacy spending directly instead of only paying claims. The tradeoff is concentration: unlike UnitedHealth, CVS/Aetna, or Elevance, it has no large commercial or PBM business to offset a bad Medicare year.

Future prospects matter as much as current results. The growth strategies below explain how Hitachi, Ltd. and Humana Inc. each plan to expand from here.

Hitachi, Ltd. growth strategy: Hitachi grows by attaching software and services to its installed base and by reshaping its portfolio. It is expanding Hitachi Energy factory capacity for transformers and HVDC, integrating Thales GTS into Hitachi Rail, and scaling Lumada through GlobalLogic and AI partnerships. On the portfolio side, it agreed in April 2026 to sell 80.1% of its home appliance business to Nojima for about $737 million (¥110 billion), continuing a long exit from consumer and commodity businesses.

Humana Inc. growth strategy: Humana's strategy under Jim Rechtin is to grow Medicare Advantage membership while rebuilding margins and quality scores. Key moves include completing the exit from employer-group commercial medical coverage in 2025, adding more than 1 million MA members for 2026, pruning about 600,000 members' worth of underperforming plans for 2027, investing in Star Ratings operations, and expanding CenterWell Senior Primary Care and CenterWell Pharmacy so that more member care runs through Humana-owned services. It is also bidding for and growing state Medicaid contracts, with a focus on members eligible for both Medicare and Medicaid.

A closer look at the financial trajectory of Hitachi, Ltd. and Humana Inc. rounds out the comparison.

Hitachi, Ltd.: Hitachi posted a ~$5.27 billion (¥787.3 billion) net loss for fiscal 2008, then the largest ever by a Japanese manufacturer. Under Takashi Kawamura and Hiroaki Nakanishi it cut loss-making consumer businesses, and later leaders sold listed subsidiaries such as Hitachi Chemical (2020), Hitachi Metals (2023), and a controlling stake in Hitachi Construction Machinery (2022). Revenue dipped from ~$72.9 billion (¥10.88 trillion) in FY2022 to ~$65.2 billion (¥9.73 trillion) in FY2023 as those units left, then climbed back to ~$71 billion (¥10.59 trillion) in FY2025 on organic growth. FY2025 adjusted EBITA was a record ~$8.78 billion (¥1.31 trillion) (12.4% margin) and net income was ~$5.38 billion (¥802.3 billion), up about 30%. In Q1 FY2026 (April-June 2026) revenue rose 20% to ~$18.2 billion (¥2,709.6 billion), helped by currency, and management raised full-year guidance.

Humana Inc.: Humana's revenue grew from $54.4 billion in 2016 to $129.66 billion in 2025, driven by Medicare Advantage enrollment and higher per-member payments. Profit moved the other way: net income fell from $3.37 billion in 2020 to $1.21 billion in 2024 and $1.19 billion in 2025 as medical costs rose faster than payments. In 2026 revenue is growing fast again: Q2 2026 revenue was $40.89 billion, up 26.2% year over year, with GAAP EPS of $5.73 and adjusted EPS of $7.61. Year-to-date operating cash flow reached $3.22 billion. Full-year 2026 guidance is adjusted EPS of at least $9.00 and GAAP EPS of at least $6.52, reflecting the Star Ratings bonus headwind.